Our exclusive "X configuration" overcomes limitations of conventional tDCS. Soterix HD-tDCS can "penetrate deeper into the brain in more focused areas", reports Nature News.
Physicians at Harvard Medical School demonstrate the application of tDCS for clinical trial on patients using a Soterix 1x1 device in this Journal of Visualized Experiments video.
HD-tDCS clinical trial underway for fibromyalgia at Harvard Medical School and Spaulding Rehabilitation Hospital, Boston.
NIH grants Soterix a Phase-1 STTR grant to develop HD-tDCS for stroke rehabilitation. The first technology capable of delivering therapeutic DC current to target brain regions involved in function recovery.
Soterix transcranial Direct Current Stimulation (tDCS) devices incorporate state-of-art technology as well as exclusive safety and comfort features. Designed to be simple to use, precise, reliable, and economical.
High-Definition tDCS (HD-tDCS) allows unprecedented targeting of brain structures with advanced targeting and control features. Soterix is the exclusive provider of HD-tDCS technology.
Fully leverage the ability of tDCS to be customized to patient and diseases. Soterix provides clinicians with unparalleled tools to design targeted and specific tDCS protocols.
The first and only stimulation device optimized for transcutaneous spinal Direct Current Stimulation (tsDCS) includes exclusive Cervical or Lumber electrode body strap and Soterix EASYpad Velcro electrodes.
Our scientific advisors and design engineers are here to help. Whether it is selecting the right Soterix device platform or customizing a design to your needs: One size does not fit all.
